Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-05
DOI
10.3389/fimmu.2022.834942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
- (2021) Shuai Wang et al. CELL RESEARCH
- Pharmacological strategies to prevent SARS-CoV-2 infection and to treat the early phases of COVID-19 disease
- (2021) Lucia Scarabel et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Dissecting the novel mechanism of Reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification
- (2021) Shanshan Jia et al. JOURNAL OF ETHNOPHARMACOLOGY
- Therapeutic targets and potential agents for the treatment of COVID‐19
- (2021) Yinuo Wu et al. MEDICINAL RESEARCH REVIEWS
- A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent
- (2021) Tianshu Xiao et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV ‐2 main protease ( 3CLpro )
- (2021) Abbas Khan et al. PHYTOTHERAPY RESEARCH
- Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein
- (2021) Chuancai Sun et al. PLoS One
- Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
- (2021) Jia-Tsrong Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein
- (2021) Shan Lu et al. Nature Communications
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
- (2021) Jarrod Shilts et al. Scientific Reports
- Advances in gene-based vaccine platforms to address the COVID-19 pandemic
- (2021) Deborah Pushparajah et al. ADVANCED DRUG DELIVERY REVIEWS
- AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19
- (2021) Steven S. Good et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
- (2021) Austin N. Spratt et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
- (2021) Shiling Hu et al. JOURNAL OF MEDICAL VIROLOGY
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- SARS-CoV-2 variants and ending the COVID-19 pandemic
- (2021) Arnaud Fontanet et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
- (2021) Meng Guo et al. Nature Reviews Gastroenterology & Hepatology
- Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
- (2021) Wanchao Yin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
- (2021) Donald J. Benton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
- (2021) Katerina Naydenova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
- (2021) Rory D. de Vries et al. SCIENCE
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
- (2021) Jerzy Osipiuk et al. Nature Communications
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- Evolutionary analysis and lineage designation of SARS-CoV-2 genomes
- (2021) Xiaolu Tang et al. Science Bulletin
- In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease
- (2021) Tien Huynh et al. Frontiers in Chemistry
- The COVID-19 puzzle: a global nightmare
- (2021) Hafiza Salaha Mahrosh et al. ENVIRONMENT DEVELOPMENT AND SUSTAINABILITY
- Decoding the Mechanism of Huanglian Jiedu Decoction in Treating Pneumonia Based on Network Pharmacology and Molecular Docking
- (2021) Xianhai Li et al. Frontiers in Cell and Developmental Biology
- The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking
- (2021) Yu Cai et al. Annals of Palliative Medicine
- Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
- (2021) Jungsoon Lee et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- Potential antiviral activity of isorhamnetin against SARS‐CoV ‐2 spike pseudotyped virus in vitro
- (2021) Yingzhuan Zhan et al. DRUG DEVELOPMENT RESEARCH
- Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin
- (2021) Gajanan Sapkal et al. JOURNAL OF TRAVEL MEDICINE
- Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
- (2021) Shuofeng Yuan et al. NATURE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The emerging plasticity of SARS-CoV-2
- (2021) Kevin D. McCormick et al. SCIENCE
- Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
- (2021) Nuno R. Faria et al. SCIENCE
- SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
- (2021) Irwin Jungreis et al. Nature Communications
- SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
- (2021) Artem Nemudryi et al. Cell Reports
- Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection
- (2021) Koen Vandyck et al. Current Opinion in Virology
- Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021
- (2021) Corinne N. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
- (2021) Marion Schuller et al. Science Advances
- The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection
- (2021) Antonella D’Amore et al. Cells
- mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
- (2021) Susanne Rauch et al. npj Vaccines
- Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
- (2021) Keivan Zandi et al. Microorganisms
- Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study
- (2021) Xiaolong Xu et al. Annals of Palliative Medicine
- Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome
- (2021) Albert Morales et al. Biomedicines
- Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation
- (2021) Wei Wang et al. ACTA PHARMACOLOGICA SINICA
- Safety, tolerability, pharmacokinetics and immunogenicity of a monoclonal antibody (SCTA01) targeting SARS-CoV-2 in healthy adults: A randomized, double-blind, placebo-controlled, phase I study
- (2021) Yinjuan Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico
- (2021) Abril Paulina Rodríguez-Maldonado et al. ARCHIVES OF VIROLOGY
- Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
- (2021) Shetty Ravi Dyavar et al. BIOMEDICINE & PHARMACOTHERAPY
- Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic
- (2021) Ben Jackson et al. CELL
- COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
- (2021) Muge Cevik et al. CELL
- The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages
- (2021) Darren P. Martin et al. CELL
- TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells
- (2021) Jana Koch et al. EMBO JOURNAL
- Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis
- (2021) James S. O’Donnell et al. INTENSIVE CARE MEDICINE
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China
- (2021) Yu Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- SARS‐CoV‐2 R.1 lineage variants that prevailed in Tokyo in March 2021
- (2021) Katsutoshi Nagano et al. JOURNAL OF MEDICAL VIROLOGY
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites
- (2021) Siennah R. Miller et al. MOLECULAR PHARMACOLOGY
- A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2
- (2021) Burcu Ucar et al. NANOTECHNOLOGY
- Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
- (2021) Jingyou Yu et al. NATURE
- The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology
- (2021) Bas B. Oude Munnink et al. NATURE MEDICINE
- Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
- (2021) Alina Tscherne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19: Epidemiologie und Mutationen
- (2021) Christoph J. Hemmer et al. RADIOLOGE
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
- (2021) Ayan Dey et al. VACCINE
- Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study
- (2021) Peng Yin et al. Virology Journal
- Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
- (2021) Bin Yang et al. Nature Communications
- Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
- (2021) Heping Wang et al. Frontiers in Pharmacology
- Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
- (2021) Axel Bauer et al. Lancet Respiratory Medicine
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
- (2021) Robert J. Ragotte et al. mSphere
- Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
- (2021) Rana Abdelnabi et al. EBioMedicine
- Recent advances in developing small-molecule inhibitors against SARS-CoV-2
- (2021) Rong Xiang et al. Acta Pharmaceutica Sinica B
- Traditional Chinese medicine in COVID-19
- (2021) Ming Lyu et al. Acta Pharmaceutica Sinica B
- IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
- (2021) Oscar Guzmán-Martínez et al. Vaccines
- Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
- (2021) Muhammad Fayyaz ur Rehman et al. Antibiotics-Basel
- Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
- (2021) Angel Yun-Kuan Thye et al. Biomedicines
- The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
- (2021) Mohamed Moubarak et al. Life-Basel
- Computational modeling predicts potential effects of the herbal infusion “horchata” against COVID-19
- (2021) Eduardo Tejera et al. FOOD CHEMISTRY
- A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan
- (2021) Tsuyoshi Sekizuka et al. INFECTION GENETICS AND EVOLUTION
- Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
- (2021) Katherine Laiton-Donato et al. INFECTION GENETICS AND EVOLUTION
- Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon
- (2021) Gédéon Prince Manouana et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
- (2021) Saathvik R. Kannan et al. JOURNAL OF AUTOIMMUNITY
- Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model
- (2021) Susan Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India
- (2021) Girish C. Dash et al. JOURNAL OF MEDICAL VIROLOGY
- Precautionary measures for more transmissible C.1.2 COVID‐19 variant: A caution for Qatar and the rest of the world
- (2021) Soha S. Albayat et al. JOURNAL OF MEDICAL VIROLOGY
- SARS‐CoV‐2 variant with mutations in N gene affecting detection by widely used PCR primers
- (2021) Pia Laine et al. JOURNAL OF MEDICAL VIROLOGY
- Changing predominant SARS‐CoV‐2 lineages drives successive COVID‐19 waves in Malaysia, February 2020 to March 2021
- (2021) I‐Ching Sam et al. JOURNAL OF MEDICAL VIROLOGY
- Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight
- (2021) Zohreh Esam et al. JOURNAL OF MOLECULAR STRUCTURE
- COVID-19 ARDS: getting ventilation right
- (2021) Xosé L Pérez-Fernández et al. LANCET
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- (2021) Raches Ella et al. LANCET
- CoronaVac induces lower neutralising activity against variants of concern than natural infection
- (2021) Vimvara Vacharathit et al. LANCET INFECTIOUS DISEASES
- Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
- (2021) Keiya Uriu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
- (2021) Jian Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
- (2021) Matthew Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
- (2021) Simone Lanini et al. Science Translational Medicine
- Analysis of SARS-CoV-2 Genomes from West Java, Indonesia
- (2021) Azzania Fibriani et al. Viruses-Basel
- Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions
- (2021) Gytis Dudas et al. Nature Communications
- Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
- (2021) Yao Zhao et al. Protein & Cell
- Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages: Implications for Coronavirus Disease 2019 (COVID-19) Therapy
- (2021) Yujia Li et al. Frontiers in Pharmacology
- Emerging SARS-CoV-2 variants expand species tropism to murines
- (2021) Huiping Shuai et al. EBioMedicine
- The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America
- (2021) Pedro E. Romero et al. Microbiology Spectrum
- Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
- (2021) Li Zhang et al. Communications Biology
- Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
- (2021) Anolin Aslan et al. Pneumonia
- SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
- (2021) Mohammad Darvishi et al. Gene Reports
- Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
- (2020) Shuai Xia et al. Cellular & Molecular Immunology
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- COVID ‐19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
- (2020) Theoharis C. Theoharides BIOFACTORS
- Potential Therapeutic Targets and Promising Drugs for Combating SARS‐CoV‐2
- (2020) Hong Zhou et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
- (2020) Gregory D. Sempowski et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
- (2020) Rameez Jabeer Khan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
- (2020) Yuanmei Zhu et al. JOURNAL OF VIROLOGY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Structure of the RNA-dependent RNA polymerase from COVID-19 virus
- (2020) Yan Gao et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
- (2020) Wen-Hsiang Chen et al. Human Vaccines & Immunotherapeutics
- The potential insights of Traditional Chinese Medicine on treatment of COVID-19
- (2020) Tong Tong et al. Chinese Medicine
- SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors
- (2020) Stephen Milne et al. Lancet Respiratory Medicine
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
- (2020) Xiaoyan Liu et al. Acta Pharmaceutica Sinica B
- The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
- (2020) Xi Wang et al. Cell Discovery
- Molecular Insights into Small Molecule Drug Discovery for SARS‐CoV‐2
- (2020) Haibin Su et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
- (2020) Mehdi Bouhaddou et al. CELL
- Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex
- (2020) James Chen et al. CELL
- A Thermostable mRNA Vaccine against COVID-19
- (2020) Na-Na Zhang et al. CELL
- Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
- (2020) Quyuan Tao et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19)
- (2020) Qiongshuai Zhang et al. MEDICINE
- Coronavirus vaccines leap through safety trials — but which will work is anybody’s guess
- (2020) Ewen Callaway NATURE
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
- (2020) Donghyuk Shin et al. NATURE
- Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
- (2020) Vijendra Ramlall et al. NATURE MEDICINE
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
- (2020) Jiangdong Huo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis
- (2020) Ming Liu et al. PHARMACOLOGICAL RESEARCH
- Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19)
- (2020) Yu-Feng Huang et al. PHARMACOLOGICAL RESEARCH
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses
- (2020) Ayal B. Gussow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
- (2020) Sepideh Sadegh et al. Nature Communications
- Immunological and inflammatory profiles in mild and severe cases of COVID-19
- (2020) Jin-Wen Song et al. Nature Communications
- Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
- (2020) Daniel W. Kneller et al. Nature Communications
- Structures of the SARS ‐CoV‐2 nucleocapsid and their perspectives for drug design
- (2020) Ya Peng et al. EMBO JOURNAL
- Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
- (2020) Tarek Mohamed Abd El-Aziz et al. INFECTION GENETICS AND EVOLUTION
- SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase
- (2020) Mark Andrew White et al. Journal of Physical Chemistry Letters
- Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors
- (2020) A. S. Achutha et al. JOURNAL OF PROTEOME RESEARCH
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Reduning injection combined with western medicine for pneumonia
- (2020) Chenggang Cao et al. MEDICINE
- Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
- (2020) Donald J. Benton et al. NATURE
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- Whither COVID-19 vaccines?
- (2020) Laura DeFrancesco NATURE BIOTECHNOLOGY
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- NARINGENIN IS A POWERFUL INHIBITOR OF SARS-CoV-2 INFECTION IN VITRO
- (2020) Nicola Clementi et al. PHARMACOLOGICAL RESEARCH
- Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
- (2020) Lu XIA et al. PHYTOMEDICINE
- A role for quercetin in coronavirus disease 2019 (COVID‐19)
- (2020) Giuseppe Derosa et al. PHYTOTHERAPY RESEARCH
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
- (2020) Suzanne J. F. Kaptein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
- (2020) Longxing Cao et al. SCIENCE
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- Quantitative proteomic analysis of the tizoxanide effect in vero cells
- (2020) K. A. Yamamoto et al. Scientific Reports
- Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
- (2020) Narasimha M. Beeraka et al. Frontiers in Immunology
- Crystal structure of SARS-CoV-2 papain-like protease
- (2020) Xiaopan Gao et al. Acta Pharmaceutica Sinica B
- Effects of Tanreqing Capsule on the negative conversion time of nucleic acid in patients with COVID-19: A retrospective cohort study
- (2020) Xing Zhang et al. Journal of Integrative Medicine-JIM
- Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
- (2020) Anna Artese et al. DRUG RESISTANCE UPDATES
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions
- (2020) Christopher R. Carlson et al. MOLECULAR CELL
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
- (2020) Shuai Yuan et al. MOLECULAR CELL
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
- (2020) Yfat Yahalom-Ronen et al. Nature Communications
- SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication
- (2020) Soren Alexandersen et al. Nature Communications
- Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
- (2020) Michael A Matthay et al. Lancet Respiratory Medicine
- Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
- (2020) Xia Xiao et al. Frontiers in Immunology
- Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
- (2020) Eleni Pitsillou et al. Frontiers in Chemistry
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
- (2019) Shuai Xia et al. Science Advances
- Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
- (2019) Pui Wang et al. mBio
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion byPlasmodium falciparum
- (2018) Meng-Yao Zhang et al. BLOOD
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- VFDB 2019: a comparative pathogenomic platform with an interactive web interface
- (2018) Bo Liu et al. NUCLEIC ACIDS RESEARCH
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
- (2014) Lu Lu et al. Nature Communications
- RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests
- (2011) Laetitia Ninove et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now